BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29308904)

  • 1. PET Imaging of VCAM-1 Expression and Monitoring Therapy Response in Tumor with a
    Zhang X; Liu C; Hu F; Zhang Y; Wang J; Gao Y; Jiang Y; Zhang Y; Lan X
    Mol Pharm; 2018 Feb; 15(2):609-618. PubMed ID: 29308904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of
    Zhang X; Hu F; Liu C; Yin L; Zhang Y; Zhang Y; Lan X
    Contrast Media Mol Imaging; 2018; 2018():7832805. PubMed ID: 29853809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody.
    Lv G; Sun X; Qiu L; Sun Y; Li K; Liu Q; Zhao Q; Qin S; Lin J
    J Nucl Med; 2020 Jan; 61(1):117-122. PubMed ID: 31253743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel single-chain variant of antibody against mesothelin established by phage library.
    Yakushiji H; Kobayashi K; Takenaka F; Kishi Y; Shinohara M; Akehi M; Sasaki T; Ohno E; Matsuura E
    Cancer Sci; 2019 Sep; 110(9):2722-2733. PubMed ID: 31461572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide.
    Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C
    Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Biological Evaluation of
    Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
    Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.
    Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL
    Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.
    Brand C; Longo VA; Groaning M; Weber WA; Reiner T
    Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M
    Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
    Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
    Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
    England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W
    Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallium-68-labeled anti-HER2 single-chain Fv fragment: development and in vivo monitoring of HER2 expression.
    Ueda M; Hisada H; Temma T; Shimizu Y; Kimura H; Ono M; Nakamoto Y; Togashi K; Saji H
    Mol Imaging Biol; 2015 Feb; 17(1):102-10. PubMed ID: 25049073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis.
    Zhang A; Wu T; Bian L; Li P; Liu Q; Zhang D; Jin Q; Zhang J; Huang G; Song S
    Mol Imaging Biol; 2020 Jun; 22(3):515-525. PubMed ID: 31250330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive Detection of HER2 Expression in Gastric Cancer by
    Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z
    Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Evaluation of [
    Peng T; Wang X; Li Z; Bi L; Gao J; Yang M; Wang Y; Yao X; Shan H; Jin H
    Mol Pharm; 2021 Sep; 18(9):3638-3648. PubMed ID: 34424706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.
    Kang CM; Kim SM; Koo HJ; Yim MS; Lee KH; Ryu EK; Choe YS
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):198-206. PubMed ID: 23096079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Translation of [
    Xavier C; Blykers A; Laoui D; Bolli E; Vaneyken I; Bridoux J; Baudhuin H; Raes G; Everaert H; Movahedi K; Van Ginderachter JA; Devoogdt N; Caveliers V; Lahoutte T; Keyaerts M
    Mol Imaging Biol; 2019 Oct; 21(5):898-906. PubMed ID: 30671739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ImmunoPET imaging of human CD8
    Zhao H; Wang C; Yang Y; Sun Y; Wei W; Wang C; Wan L; Zhu C; Li L; Huang G; Liu J
    J Nanobiotechnology; 2021 Feb; 19(1):42. PubMed ID: 33563286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.